Resalis Therapeutics
- Biotech or pharma, therapeutic R&D
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity.
June 16-19, 2025
Boston Convention & Exhibition Center
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity.